|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.028 EUR | -1.34% |
|
-4.77% | +5.38% |
| 06-12 | Aegon Ltd. - Shareholder/Analyst Call | |
| 06-02 | Berenberg Ups Aegon Price Target on Potential US Mortality Improvement | MT |
| Capitalization | 9.6B 11.1B 9.01B 8.16B 15.07B 955B 17.05B 105B 40.96B 437B 41.65B 40.75B 1,598B | P/E ratio 2025 * |
8.24x | P/E ratio 2026 * | 7.42x |
|---|---|---|---|---|---|
| Enterprise value | 11.57B 13.38B 10.86B 9.84B 18.17B 1,152B 20.55B 127B 49.38B 527B 50.21B 49.12B 1,926B | EV / Sales 2025 * |
1.18x | EV / Sales 2026 * | 1.15x |
| Free-Float |
64.55% | Yield 2025 * |
6.48% | Yield 2026 * | 7.06% |
More valuation ratios
* Estimated data
More news
Last Transcript: Aegon Ltd.
| 1 day | -1.34% | ||
| 1 week | -4.77% | ||
| Current month | -4.41% | ||
| 1 month | -0.72% | ||
| 3 months | +3.93% | ||
| 6 months | -1.21% | ||
| Current year | +5.38% |
| 1 week | 5.98 |  | 6.37 |
| 1 month | 5.96 | | 6.39 |
| Current year | 4.79 | | 6.54 |
| 1 year | 4.79 | | 6.54 |
| 3 years | 3.71 | | 6.54 |
| 5 years | 1.99 | | 6.54 |
| 10 years | 1.56 | | 7.22 |
| Manager | Title | Age | Since |
|---|---|---|---|
Eilard Friese
CEO | Chief Executive Officer | 62 | 14/05/2020 |
Duncan Russell
DFI | Director of Finance/CFO | 47 | 31/08/2024 |
Deborah Waters
CTO | Chief Tech/Sci/R&D Officer | 58 | 06/02/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Dona Young
BRD | Director/Board Member | 71 | 14/05/2013 |
| Director/Board Member | 66 | 20/05/2014 | |
| Chairman | 67 | 17/05/2018 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.34% | -4.77% | +3.97% | +38.48% | 11.1B | ||
| -0.60% | +2.00% | +31.91% | +23.43% | 126B | ||
| -0.62% | -2.55% | +34.47% | +88.20% | 105B | ||
| -0.44% | -1.45% | +17.03% | +90.14% | 55.24B | ||
| -3.20% | -4.68% | +22.33% | +92.28% | 53.25B | ||
| -1.47% | -5.14% | +32.67% | +98.90% | 53.83B | ||
| -2.08% | -3.23% | +12.66% | +26.72% | 51.92B | ||
| -0.42% | +2.66% | +27.75% | +68.67% | 43.64B | ||
| -1.84% | -2.47% | -9.65% | +9.25% | 36.45B | ||
| -1.27% | -2.34% | +33.90% | +45.73% | 36.23B | ||
| Average | -1.33% | -1.70% | +20.70% | +58.18% | 57.25B | |
| Weighted average by Cap. | -1.17% | -1.22% | +25.00% | +59.76% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 9.84B 11.38B 9.24B 8.37B 15.45B 980B 17.48B 108B 42.01B 449B 42.71B 41.79B 1,638B | 10.04B 11.61B 9.42B 8.54B 15.77B 1T 17.83B 110B 42.86B 458B 43.57B 42.63B 1,672B |
| Net income | 1.23B 1.42B 1.15B 1.04B 1.92B 122B 2.18B 13.44B 5.23B 55.84B 5.32B 5.2B 204B | 1.3B 1.5B 1.22B 1.1B 2.04B 129B 2.3B 14.22B 5.53B 59.08B 5.63B 5.5B 216B |
| Net Debt | 1.97B 2.28B 1.85B 1.68B 3.1B 196B 3.5B 21.63B 8.41B 89.84B 8.56B 8.37B 328B | 1.97B 2.28B 1.85B 1.68B 3.1B 196B 3.5B 21.63B 8.41B 89.84B 8.56B 8.37B 328B |
More financial data
* Estimated data
Employees
15,582
Sector
Life & Health Insurance
Calendar
06-15
- Final dividend
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/06/25 | 6.028 € | -1.34% | 6,473,143 |
| 12/06/25 | 6.110 € | -2.92% | 8,936,213 |
| 11/06/25 | 6.294 € | -0.25% | 4,649,258 |
| 10/06/25 | 6.310 € | -0.28% | 4,654,400 |
| 09/06/25 | 6.328 € | -0.03% | 2,662,523 |
End-of-day quote Euronext Amsterdam, June 12, 2025
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
6.028EUR
Average target price
6.783EUR
Spread / Average Target
+12.53%
Annual profits - Rate of surprise
- Stock Market
- Equities
- AGN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition